Industry NewsDrug Discovery & Development
Sygnature Discovery appoints new vice president
Leading discovery operations worldwide, new VP brings 30 years of experience and a proven track record of success to the role
News & Articles
Results per page
25
10 Articles Found | Selected Filters:
Industry NewsDrug discovery > Target Discovery
Sygnature Discovery acquires Peak Proteins to strengthen its drug discovery capabilities
Peak Proteins' expertise in protein crystallography will enhance Sygnature Discovery’s fragment screening and analysis activities as well as its structure-based drug design capabilities
Industry NewsDrug discovery > Lead Discovery
Sygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities
Automated sample storage for multi-customer, multi-year storage HTS relationships
Industry NewsDrug discovery > Lead Discovery
Sygnature Discovery boosts senior management team with appointment of Dr Paul Overton
In this newly created role, he will work alongside Dr Paul Clewlow, Senior VP, Business Development and Executive Board Director
Industry NewsDrug discovery > Lead Discovery
Sygnature expands capabilities with acquisition of Alderley Oncology
Deal enables a wider suite of pre-clinical testing services in oncology
